Health Care & Life Sciences » Biotechnology | Beijing Tiantan Biological Products Corp. Ltd.

Beijing Tiantan Biological Products Corp. Ltd. A | Mutual Funds

Mutual Funds that own Beijing Tiantan Biological Products Corp. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
8,325,208
0.96%
247,835
1.12%
12/31/2017
2,503,397
0.28%
-597,700
1.96%
12/31/2017
Nanfang CSI 500 ETF
1,859,446
0.21%
-106,210
0.25%
12/31/2017
1,335,529
0.15%
-476,438
0.79%
12/31/2017
1,313,638
0.15%
1,313,638
0.53%
12/31/2017
701,241
0.08%
-32,240
3.31%
12/31/2017
552,471
0.06%
-85,423
0.71%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
462,926
0.05%
0
0%
07/31/2018
461,370
0.05%
461,370
0.78%
12/31/2017
374,790
0.04%
374,790
0.56%
12/31/2017

About Beijing Tiantan Biological Products Corp.

View Profile
Address
No.4 Sanjianfang South Li
Beijing Beijing 100024
China
Employees -
Website http://www.tiantanbio.com
Updated 07/08/2019
Beijing Tiantan Biological Products Corp. Ltd. engages in the research and development, production, and sale of biological products. It offers blood albumin; intravenous, hepatitis B and tetanus immunoglobulin; coagulation factors; and protease inhibitors. The company was founded on June 8, 1998 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.